SCHEMBL13290403

SCHEMBL13290403

CCOCCC(=O)NCCCCNC(=O)Cc1c(C)n(C(O)c2ccc(C)cc2)c2ccc(OC)cc12

nearest known ligand 0.48

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 15/20 0.48
PLA2G2A P14555 2/20 0.47
PTGS1 P23219 3/20 0.47
HDAC3 O15379 3/20 0.46
HDAC1 Q13547 3/20 0.46
HDAC8 Q9BY41 3/20 0.46
HDAC6 Q9UBN7 3/20 0.46
HDAC2 Q92769 1/20 0.46
HRH4 Q9H3N8 1/20 0.46
CA12 O43570 1/20 0.43
CA1 P00915 1/20 0.43
CA2 P00918 1/20 0.43
CA4 P22748 1/20 0.43
CA9 Q16790 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13290405 0.90 PTGS2 (0.52) PTGS2PLA2G2APTGS1HDAC3HDAC1
SCHEMBL13290393 0.83 PTGS2 (0.69) PTGS2PTGS1HDAC3HDAC1HDAC8
SCHEMBL13286883 0.77 PTGS2 (0.80) PTGS2PTGS1HDAC3HDAC1HDAC8
SCHEMBL14351096 0.76 PTGS2 (0.65) PTGS2PTGS1HDAC3HDAC1HDAC8
SCHEMBL878348 0.74 PLA2G2A (0.46) PLA2G2ACA12CA4CA9
SCHEMBL18517535 0.73 PTGS2 (0.59) PTGS2
SCHEMBL18517424 0.71 PTGS2 (0.56) PTGS2PLA2G2A
SCHEMBL13290394 0.71 PTGS2 (0.49) PTGS2PLA2G2APTGS1HDAC3HDAC1
SCHEMBL13290332 0.69 PTGS2 (0.57) PTGS2PLA2G2APTGS1HDAC3HDAC1
SCHEMBL10147607 0.68 CA12 (0.50) PTGS2PLA2G2APTGS1HRH4CA12

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7736624-B2 derivatives of non-steroidal anti-inflammatory drugs that exhibit selective binding to cyclooxygenase-2 (COX-2) and that comprise functional groups allowing them to be used for medical diagnosis and/or as therapeutic agents; tissue-targeted therapy UNIV VANDERBILT (US) 2010-06-15 US disclosed